GAA
ARCT icon

Green Alpha Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Green Alpha Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$400K Buy
29,234
+2,143
+8% +$22.4K 0.27% 88
2026
Q2 		$182K Sell
27,091
-1,047
-4% -$8.25K 0.12% 103
2026
Q1 		$217K Sell
28,138
-144
-0.5% -$1.05K 0.21% 92
2025
Q4 		$173K Buy
28,282
+6,839
+32% +$73.9K 0.16% 102
2025
Q3 		$395K Sell
21,443
-4,539
-17% -$72.9K 0.38% 74
2025
Q2 		$338K Sell
25,982
-1,249
-5% -$14.8K 0.32% 84
2025
Q1 		$288K Buy
+27,231
New +$432K 0.31% 86
2024
Q2 		– Sell
-8,414
Closed -$284K – 139
2024
Q1 		$284K Buy
8,414
+20
+0.2% +$709 0.21% 124
2023
Q4 		$265K Sell
8,394
-13,144
-61% -$312K 0.19% 137
2023
Q3 		$550K Sell
21,538
-2,282
-10% -$70.3K 0.42% 89
2023
Q2 		$683K Sell
23,820
-615
-3% -$16.7K 0.45% 84
2023
Q1 		$586K Buy
24,435
+994
+4% +$17.8K 0.41% 94
2022
Q4 		$398K Buy
23,441
+79
+0.3% +$1.38K 0.33% 108
2022
Q3 		$346K Sell
23,362
-52,888
-69% -$888K 0.29% 120
2022
Q2 		$1.2M Buy
76,250
+53,237
+231% +$1.04M 0.28% 71
2022
Q1 		$620K Buy
23,013
+2,064
+10% +$52.7K 0.42% 98
2021
Q4 		$775K Buy
20,949
+726
+4% +$29.6K 0.52% 87
2021
Q3 		$966K Buy
20,223
+2,101
+12% +$94.1K 0.67% 73
2021
Q2 		$613K Buy
+18,122
New +$613K 0.42% 108

Other funds holding ARCT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

Green Alpha Advisors's ARCT Position: Q3 2026 in Review

Green Alpha Advisors increased its Arcturus Therapeutics (ARCT) stake by 7.9% in Q3 2026, buying an estimated $22.4K and bringing the position to 29,234 shares worth $400K. The position accounts for 0.27% of the portfolio, ranked #88.

Green Alpha Advisors first reported a position in ARCT in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.2M in Q2 2022. 10 funds tracked by Wall St. Rank hold ARCT as of Q3 2026.

  • Green Alpha Advisors held 29,234 shares of Arcturus Therapeutics worth $400K as of Q3 2026.
  • Green Alpha Advisors bought 2,143 Arcturus Therapeutics shares in Q3 2026, an estimated $22.4K.
  • Arcturus Therapeutics made up 0.27% of Green Alpha Advisors's portfolio in Q3 2026, its #88 holding.
  • Green Alpha Advisors first reported a position in Arcturus Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Green Alpha Advisors's Arcturus Therapeutics position peaked at $1.2M in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.